Name of trial Trial registry entries | Type of trial | Country | Participants | Inclusion criteria | Exclusion criteria | Study number | Time of study |
---|---|---|---|---|---|---|---|
LADIES ClinicalTrials.gov Identifier: NCT01317485 | Multicentre two-armed randomised trial: 34 teaching hospitals and eight academic hospitals in Belgium, Italy, and the Netherlands | The Netherlands | Patients with generalised purulent and faecal peritonitis from sigmoid diverticulitis | Clinical signs of peritonitis. Free gas on and/or diffuse fluid on CT LOLA arm: Only patients with purulent perforated diverticulitis without overt perforation | Dementia Previous sigmoidectomy Prior pelvic irradiation, Chronic treatment with high-dose steroids (>20Â mg daily) Being aged younger than 18Â years or older than 85Â years Preoperative shock needing inotropic support Patients with Hinchey I and II Patients with Hinchey IV peritonitis or overt perforation were excluded from the DIVA group | LOLA arm: 264 DIVA arm: 212 | LOLA arm: between July 2010, and the early termination of the trial February 2013 |
DILALA trial ISRCTN for clinical trials ISRCTN82208287 | Multicentre randomised trial | Sweden- Denmark | Perforated non-faeculent diverticulitis | Hinchey grade III at diagnostic laparoscopy, i.e. free fluid | Hinchey grade I - II at laparoscopy i.e. no free fluid Hinchey grade IV at laparoscopy, i.e. gross faecal contamination. Other pathology than diverticulitis diagnosed as explanation of peritonitis | 80 | Between February 2010 until February 2014 |
SCANDIV ClinicalTrials.gov Identifier: NCT01047462 | Multicentre randomised trial | Sweden- Norvey | Perforated non-faeculent diverticulitis | Patients with generalised peritonitis | Pregnancy Bowel obstruction | 199 | Between February 2010 until June 2014 |